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Retinoid signaling has been implicated in embryonic stem cell differentiation. Here we present a
systematic analysis of gene expression changes in mouse embryonic stem cells (mESCs), during their
spontaneous differentiation into embryoid bodies and the effect of all-trans retinoic acid (ATRA) on
this process. We show that retinoic acid is present in the serum and is sufﬁcient to activate retinoid
signaling at a basal level in undifferentiated mESCs. This signal disappears during embryoid body
formation. However exogenously added ATRA resets the spontaneous differentiation programs in
embryoid bodies and initiates a distinct genetic program. These data suggest that retinoid signaling
not only promotes a particular pathway but also acts as a context dependent general coordinator of
the differentiation states in embryonic stem cells.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
All-trans retinoic acid (ATRA), a biologically active form of vita-
min A, plays an important role in many diverse biological pro-
cesses, such as embryogenesis and cellular differentiation. ATRA
acts through the Retinoic acid receptor (RAR) and regulates gene
expression. Both ATRA and its receptors have been implicated in
embryonic development. Endogenous ATRA can be detected
in vivo as early as in 3.5 day-blastocyst but it disappears at day
6.5 [1,2]. The role of such transient RA production is largely
unknown.
Embryonic stem cells (ESCs) are pluripotent cells isolated from
the inner cell mass of blastocysts (day 3.5). Aggregates of ES cells –
termed embryoid bodies (EB) – resemble normal embryonic
development much closer than previously thought, and provide achemical Societies. Published by E
istry and Molecular Biology,
en, Hungary. Fax: +36 52 314
k.valuable in vitro model for studying the effects of various factors
on cell lineage decisions in early stages of mammalian embryonic
development [3].
Retinoid signaling can promote ESC differentiation into neu-
rons, adipocytes, osteoblasts, pancreatic b cells, and primitive
endoderm like cells in vitro depending on culture conditions [4].
In contrast, it has also been shown that ATRA treatment of ES cells
for 72 h induces LIF expression [5], which is essential for the self-
renewal of ES cells [6], suggesting that the effect of retinoid signal-
ing is likely to be context dependent.
Thus, we decided to carry out comprehensive gene expression
analyses in order to detect retinoid signaling and also to deter-
mine the impact of exogenously added ATRA on the spontaneous
differentiation program of ESCs and EBs. The results of our global
gene expression analyses provide evidence for the presence of
RA-signaling activity in undifferentiated ES cells that comes from
the ATRA content of the serum. We also demonstrate that short-
term ATRA treatment has an unexpected effect on the differenti-
ating cells: it is able to partly reverse spontaneous differentiation
and redirect the lineage commitment in early phases of the dif-
ferentiation by resetting ES-like gene expression patterns. These
observations provide support for the concept of context depen-
dent retinoid activity in early stages of embryonic development.lsevier B.V. All rights reserved.
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2.1. mESC culture and neural differentiation
Mouse ESCs (a clone of D3) were cultured as described previ-
ously [7]. ES medium contained 15% ES qualiﬁed FBS (Cat. No.:
SH30070.03, HyClone Laboratories, Inc., Utah). For the induction
of EB formation cells were aggregated in 100-mm bacteriological
dishes (Greiner) at a speciﬁc density (4  106 cells/15 ml) in the
absence of LIF. For the ligand treatments medium was supple-
mented with ATRA (Sigma) in 0.05–5 lM concentration or with
DMSO as a control. BMS493 (inverse RAR agonist, kind gift from
H. Gronemeyer) was used in 1 lM ﬁnal concentration [8].
2.2. Real-time quantitative RT-PCR
Total RNA was isolated with TRIZOL reagent (Invitrogen). cDNA
synthesis was performed with High Capacity cDNA Reverse Tran-
scription kit (Applied Biosystems) according to the manufacturer’s
recommendation. Quantitative PCR was performed using real-time
PCR (ABI PRISM 7900, Applied Biosystems). Gene expression was
quantiﬁed by the comparative CT method and normalized to Cyclo-
philin expression. Values are expressed as mean ± S.D. of the mean.
GraphPad Prism version 5.02 was used for data interpretation. The
sequences of the primers and probes are available upon request.
2.3. Microarray analysis
Total RNA was puriﬁed by using the RNeasy kit (Qiagen). The
amount and quality of total RNA was determined by Agilent 2100
Bioanalyzer (Agilent Technologies) and by NanoDrop ND1000
(NanoDrop Technologies). Sense-strand cDNA was generated from
250 ng total RNA using AmbionWT Expression Kit. Fragmentation
and labeling was performed using the Affymetrix GeneChip WT
terminal Labeling Kit. All kits were used according to the manufac-
turer’s recommendation. GeneChip Mouse Gene 1.0 ST Arrays were
used toobtainwhole-genomegene-level expressiondata.Data anal-
ysis was performed using GeneSpring GX 11.0 software (Agilent,
Santa Clara, CA). Affymetrix data ﬁles were imported to the Gene-
Spring by RMA16 algorithm. Normalization to themedian of control
sampleswasperformed.Differential expressionanalysiswas carried
out to determine the number of changing entities during EB forma-
tion by using unpaired T-test, Asymptotic p-value computation and
Benjamini–Hochberg multiple testing correction. Hierarchical clus-
ter analysis was performed using Euclidean distance metric. All
microarray data from this study have been submitted to the Gene
Expression Omnibus (Series accession number: GSE20919).
2.4. Determination of ATRA and retinol concentration
Concentrations of ATRA and retinol were measured in serum
and undifferentiated ES cells by our Liquid Chromatography–Mass
Spectrometry (LC–MS) method described previously [9].3. Results and discussion
3.1. Retinoic acid signaling activity in undifferentiated ESCs
As a ﬁrst step of our studies we wanted to determine whether
ATRA induced response in gene expression can be detected in
undifferentiated ESCs. As Fig. 1A shows, exogenous ATRA treat-
ment induced expression of target genes, such as Hoxa1 and
Cyp26a1 in a time and dose dependent manner.
We decided to investigate a simple differentiation system con-
sisting of feeder-free undifferentiated ES cells and four-day oldembryoid bodies (Supplementary 1A and B) as model systems in
order to gain insights into the expression pattern of the elements
of the retinoid signaling pathway depicted on Fig. 1B. We found,
using global gene expression analyses, that RDHs, Crabp1, RARs
(Rarg, Rarb) and RXRs (Rxra, Rxrb) are expressed at readily detect-
able levels in ES cells. RBPs, ALDHs and Cyp26s are present at very
low mRNA levels (Fig. 1C). These results suggest that endogenous
production of RA is unlikely to take place in ES cells. However, as
these cells express RARs, RXRs and Crabp1 required for RA re-
sponse it is conceivable that endogenous retinoids had the poten-
tial to regulate gene expression. Therefore we have determined the
amount of ATRA present in the serum used for maintaining the
cells. ATRA was detectable in the ES qualiﬁed serum (1 nM in ﬁ-
nal concentration) by an LC–MSmethod. Retinol content of the ser-
um was also readily detectable (200 nM) (Fig. 1D). This suggests
that the potential for receptor activation is present even in the ab-
sence of the conversion of retinol or retinal to ATRA in ESCs. To
determine whether cells indeed take up ATRA, we measured the
cytoplasmic concentration as well. We found that the undifferenti-
ated ESCs contain 0.4 ng/g ATRA (1 nM) (Fig. 1E). This amount of
cytoplasmic ATRA is within the range to activate RARs. To conﬁrm
this activity, we added an RAR inverse agonist BMS493 to the ES
cells to block endogenous retinoid signaling. As Fig. 1F shows this
inverse agonist decreased the basal expression level of Rarb, Hoxa1
and in the case of the known RA-repressed genes (Foxd3, Otx2) in-
creased the expression level suggesting that endogenous retinoid
signaling is contributing to the regulation of these genes.
Along with the fact that serum contains a large number of fac-
tors that might inﬂuence the differentiation process, a number of
research groups have turned to serum-free growth media for cul-
turing ESCs. Supplementation of serum-free medium with BMP4
inhibits differentiation of ES cells in a cooperative manner with
LIF [10]. There is no available data on how addition of retinoids
changes the ESC phenotype in such serum-free media. Further
comparative studies are required to evaluate how low RA content
of the serum might inﬂuence the ESC pluripotency and differenti-
ation in comparison with serum-free growth media.3.2. ATRA has coordinating and opposing effects on multiple lineages
during early EB formation
As the next step in our studies we sought to determine the ef-
fect of ATRA signaling on the gene expression changes accompany-
ing early EB formation during the ﬁrst four days. We investigated
EB formation during this time period in the presence or absence
of ATRA. As an indicator of lineage speciﬁcation we used a set of
germline markers. We found that ATRA primarily upregulates
markers of neuroectoderm (Tuj1, DCX, Pax6, Neurog2), pancreatic
b cells (Foxa2, Pdx1, Hnf1b), hepatocytes (Afp, Foxa2, Hnf1b) and
cardiomyocytes (Gata4, Sox17) (Fig. 2). These results are in line
with previously published results showing that RA can be used
in vitro to promotes lineage commitment into these directions.
On the other hand Fgf5 (promote cellular proliferation) and Otx2
(required for proper forebrain development) were repressed by
ATRA. Therefore EB differentiation in the presence of ATRA biasses
the spontaneous differentiation of ESCs into certain directions,
whilst other pathways appear to be repressed by the same signal.
Such a global, coordinating effect on differentiation might explain
why ATRA decreases the viability of mouse blastocysts in vitro
[11].3.3. Retinoic acid signaling disappears in differentiating EBs
Importantly, it was demonstrated that ATRA disappears at
embryonic day 6.5 in vivo [1,2].
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Fig. 1. Activity of retinoid signaling pathway in ES. (A) Time and dose dependent mRNA expression of Cyp26a1 and Hoxa1, two ATRA regulated genes in ES cells in the
presence of LIF. Cell were cultured in the absence of feeder cells. (Dose (from left to right): DMSO, 0.05 lM, 0.5 lM, 5 lM ATRA). (B) Schematic representation of retinoid
metabolism. Retinol is taken up via the retinol binding protein (Rbp) and the Rbp receptor Stra6 (not shown). The intracellular synthesis of RA is a 2-step reaction: the ﬁrst
step is the reversible oxidation of retinol into retinal by retinol dehydrogenases (Rdh) and alcohol dehydrogenases (Adh). The second step, the oxidation of retinal to the
biologically active RA, is carried out by retinal dehydrogenases (Aldh). The produced retinoic acid is bound to intracellular retinoic acid binding proteins (Crabp) and delivered
to the nucleus and loaded onto the retinoic acid receptor-retinoid X receptor heterodimer (RAR:RXR). (C) Per chip normalized microarray signal intensity data of genes
involved in retinoid signaling. Values of all probes and some known ES markers are also shown. Red line indicates the median value of all probes. One dot represents one gene.
Genes showing expression above the median were considered expressed. Gene symbols on the top of the ﬁgure indicate the dominantly expressed genes from each group,
while the genes with lower expression are colored in gray. (D) Quantity of ATRA and retinol in the ES qualiﬁed serum and cytoplasm (E) of undifferentiated ESCs determined
by LC–MS method. (F) Detection of expressional changes in RA-induced (Rarb, Hoxa1) and RA-repressed (Otx2, Foxd3) genes 6 h after ATRA or BMS493 (RAR inverse agonist)
treatment by Q-RT-PCR. Both ATRA and BMS493 were used in 1 lM ﬁnal concentration.
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signaling is reﬂected in the ESC-EB in vitro model system. We
therefore looked at the EB formation from a gene expression point
of view. Our global gene expression analyses plotted as heat map
comparison shows that cell aggregation and differentiation induce
signiﬁcant changes in the expression level of approximately 1000
genes (Fig. 3A). This is comparable both quantitatively and qualita-tively to data available in databases (eg. GDS2667, GEO dataset,
data not shown). However, we should note that EBs, selected from
the same dish are highly variable in gene expression proﬁle, and
global gene expression can measure only the average level of all
the genes of a population of cells [12].
These 1000 genes include upregulation of germline speciﬁc
markers such as Ngfr, Fgf4 and Otx2 for ectoderm, Activin C, Fgf5
Fig. 2. Differentiation promoting effect of ATRA during early EB formation. (A) Expressional changes of neural (Tuj1, DCX, Neurog2, Pax6, Otx2, Hoxa1), hepatocyte (Foxa2,
Afp, Hnf1b), pancreatic (Hnf1b, Pdx1, Foxa2), cardiomyocyte (Gata4, Sox17), bone/cartilage (Bmp2) markers as detected by Q-RT-PCR. ATRA was added in 5 lM ﬁnal
concentration or DMSO as a control.
3126 Z. Simandi et al. / FEBS Letters 584 (2010) 3123–3130and Bmp2 for mesoderm and Gata4, Hnf4a and Hnf1b for endo-
derm differentiation (Fig. 3B). Importantly, the presence of these
prototypic markers suggests that our protocol allows the differen-
tiation of precursors of all three germ layers. At this time point
stem cell markers are still not affected signiﬁcantly (Supplemen-
tary 2A). Carrying out time dependent analysis we found that stem
cell markers, such as Oct3/4 are downregulated at day 6 in our
model system (Supplementary 2B).
Focusing on retinoid signaling, we could detect statistically
signiﬁcant differences only in the level of Cyp26a1, Crabp1 and
some of the retinoid target genes, such as Egr1, Stra8 (Fig. 3C).
Marked elevation in the level of a single known RA target gene
Cyp26a1 formally suggests the potential presence of endogenous
retinoic acid in EB. Strikingly all the other known retinoid target
genes were decreasing or not changing in the EBs (i.e. Activin-A,
Rarb, Crabp1, Egr1 Stra6, Stra8 and Tgm2). All microarray results
were validated by Q-RT-PCR (Supplementary 2C) conﬁrming theobserved changes. These data suggest that Cyp26a1 might be
upregulated by other mechanisms too, independent of retinoid
signaling and via this it contributes to the elimination of all ret-
inoid signaling in EBs by day 4. To address the question whether
Cyp26a1’s expression is induced during ES-EB transition, we per-
formed EB aggregation in the presence of BMS493. Remarkably,
Cyp26a1 was upregulated both in DMSO and RAR inverse agonist
treated EBs between day 3 and day 4. These results indicates that
Cyp26a1 upregulation could not be completely eliminated by
inhibiting the retinoid pathway. Other known retinoid target
genes, such as Rarb, Hoxa1 were not induced during this period.
Another target gene Tgm2, has been downregulated in parallel
with Cyp26a1 upregulation (Fig. 3D). These additional data now
provide further support to the notion that Cyp26a1 is indeed un-
der retinoid-independent upregulation. It also suggests a poten-
tial mechanism that may be responsible for the removal of
ATRA during EB formation.
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Fig. 3. Retinoic acid signaling activity in differentiating EBs. (A) Heat map analysis of expression of genes regulated during the ES–EB transition. Expression of 1060 probes
has changed signiﬁcantly (FCP 2, P 6 0.05). (B) Heat map analysis of the expression of early ectodermal (Ngfr, Fgf4, Otx2), endodermal (Gata4, Hnf4a, Hnf1b) and
mesodermal (Activin C, Fgf5, Bmp2) differentiation markers during ES–EB transition. Color intensities reﬂect the ratios of signal intensities. (C) Heat map analysis of the
expression of retinoid pathway-related genes compared during ES–EB transition. Statistically signiﬁcant difference (FCP 2, P 6 0.05) can be detected in the level of Rbp1,
Cyp26a1, Crabp1, Dhrs9, Egr1, Inhba, Stra8 and Tgm2. (D) EB formation in the presence of RAR inverse agonist BMS493. In general, Cyp26a1, Rarb, Hoxa1, Tgm2 are positively
regulated genes, while Otx2 is repressed by ATRA.
Z. Simandi et al. / FEBS Letters 584 (2010) 3123–3130 31273.4. Short term RA treatment resets the expression of the majority of
the target genes to levels characteristic of ESCs
Using ATRA during early stages of embryonic development is
biologically relevant because it has been shown that ATRA
in vitro has an adverse effect on germ layer and subsequent neu-
rula development from day 3 to day 8 of gestation [11]. Thus, as
the next step in our study we decided to evaluate the inﬂuence
of short-term RA treatment on the spontaneous differentiation of
ESCs. Four-day old EBs were treated for 12 h with ATRA or
DMSO and global changes in gene expression were measured
by microarrays. ATRA treatment of EBs regulated almost 80
genes, most of them being upregulated (Fig. 4A). Next, we com-
pared the expression level of these early retinoid-regulated
genes in ES, DMSO or ATRA-treated EBs to each other. Impor-
tantly, a cluster analysis of the 74 annotated genes distinguishedclearly three groups of genes (Fig. 4B). We found that two-third
of the genes (Group II and III) are regulated signiﬁcantly both
during the ES–EB transition and also by the ATRA treatment.
Only one third of the ATRA regulated genes were not changed
signiﬁcantly during the ES-EB transition (Group I). More strik-
ingly the direction of change from ES to EB state for the genes
in Group II and III was reversed by ATRA treatment. Only one
gene, Cyp26a1 followed its original path both during the ES–EB
transition and during the ATRA treatment (Fig. 4C). Table 1
(expanded version in Supplementary 4) lists the common name
of the genes of the three groups and the fold change values. In
general, 12 h of ATRA treatment inﬂuenced genes mainly respon-
sible for speciﬁcation of the anterior-posterior axis and cell
proliferation.
In the ﬁrst group we could ﬁnd genes that were not changing
during the EB formation step (23 genes). These genes are
AC
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Fig. 4. Independent and reversing effects of ATRA on gene expression. (A) Heat map comparison of gene expression of DMSO vs. ATRA response. 12 h ATRA treatment has
signiﬁcantly changed the expression level of 78 entities (FCP 2, P 6 0.05). (B) Cluster analysis of 74 annotated ATRA regulated genes from the 78 probes. Three independent
groups can be identiﬁed: Group I (23 genes), Group II (10 genes), Group III (41 genes). Three entities were not annotated, while Cyp26a1 showed a different pattern (Fig. 4C).
In Table 1 the common names of genes are listed for each subgroup. (C) Expression level of Cyp26a1 determined by Q-RT-PCR. (D) Expression changes of germline markers in
ES-(EB + DMSO) and (EB + DMSO)-(EB + ATRA) transition. (E) The expression of Dhrs3, Lefty1, Foxd3 (Group I.), Otx2, Lef1 (Group III.) and Gfra1, Hoxb2, Stra8 (Group III.) was
validated by Q-RT-PCR.
3128 Z. Simandi et al. / FEBS Letters 584 (2010) 3123–3130exclusively regulated by exogenous ATRA. Consistent with the
known involvement of RA in caudalization of neuronal progenitor
cells and regulator of thebodypatterns,we found in this groupgenes
involved in these processes such as Hox genes (a1, b1, b4 and b5),
Lefty1, Cdx1, Foxd3 and Zmym3. Beside the neural differentiation,
represented by Gfra1, Pmp22 Chrna5, Cdh9, Sema3e, and in part
by the Hox genes (a1, b1, b5), the role of ATRA in other lineage com-
mitment processes is shown by the regulation of Epo (erythroid dif-
ferentiation) and Tcp11 (spermatogenesis).
In the second and third groups we can ﬁnd genes that change
their expression up and down respectively during the transition
from ESC to EB. ATRA signal resets their expression into the oppo-
site direction. Among these we can ﬁnd genes involved in cell pro-liferation (Dusp9, Foxn4), apoptosis (Cidea) and differentiation
(Erf, Hoxa3, Hoxa5, Hoxb2, Pdgfrb, Tll1, Otx2).
Not only the expression of retinoid targets but also several
germline markers are reset following ATRA treatment, like Otx2,
Ngfr, Fgf4, Fgf5, Hnf1b, Hnf4a, Gata4 (Fig. 4D). However the
changes of these markers are not signiﬁcant after 12 h. One possi-
ble explanation for these results might be that a retinoid deprived
state allows the initiation of various spontaneous differentiation
programs. An exogenous or endogenously produced retinoid signal
in this retinoid-free state would reset the gene expression pro-
grams and redirect differentiation. However, long term ATRA treat-
ment eventually leads to the well described lineage commitments,
such as neural differentiation (Supplementary 3 and 4).
Table 1
Gene list of the clustered ATRA regulated genes (expanded table in Supplementary 4).
Group I Group II Foxn4 Stra8
Acp5 Casq2 Gca Tle6
Actn3 Cdh9 Gfra1 Tll1
Cdx1 Dnmt3l Gm9697 Ttll6
Dhrs3 Lef1 Gpr124 Wdr40b
Dleu7 Mirg H2-B Zfhx2
Epo Otx2 Hal
Fbxo27 Slc17a9 Hoxa3
Foxd3 Slc27a2 Hoxa5
Greb1I Tmem154 Hoxb2
Hoxa1 Zfp459 Igsf21
Hoxb1 Mall
Hoxb4 Group III Necab2
Hoxb5 Ankrd44 Osta
Lefty1 Aqp3 Pdgfrb
Nrip1 Arhgef10 Pmp22
Pftk2 Calcoco2 Pptc7
Sema3e Chrna5 Prtg
Slc15a1 Cidea Ptprz1
Slc4a9 Clgn Raet1d
Stra6 Csn3 Rarb
Tcp11 Cyp11a1 Smyd2
Tmem229b Dusp9 Sorcs2
Zmym3 Erf Spsb1
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It is clear from these data and also from prior data available
in the literature that retinoids and retinoid signaling has a role
and impact on ESC differentiation and lineage commitment.ES
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3130 Z. Simandi et al. / FEBS Letters 584 (2010) 3123–3130second, a freshly initiated retinoid driven differentiation pro-
gram. In order to further illustrate the truly context dependent
nature of retinoid signaling we could show the retinoid-regu-
lated expression of an endoderm (Afp) and a neuroectoderm
marker (Neurog2) during the course of the differentiation para-
digm we used. On the one hand if retinoid signaling is activated
during the early phase of ESC differentiation (ﬁrst four days) it
will induce the endoderm marker, whilst the neuroectoderm
marker will only be moderately activated (Fig. 5A). On the other
hand, if retinoids provided during the second four-day period,
Afp’s expression will not be inducible and Neurog2 will be
turned on to high levels. In order to further characterize these
processes individual subgroups of cells need to be selected and
characterized by looking at gene expression changes and corre-
lating those with accompanying phenotypic changes. Experimen-
tal methods, such as cell sorting may affect cell physiology and
gene expression. A recent method, cell type-speciﬁc signiﬁcance
analysis of microarrays (csSAM) [14] may provide an appropriate
approach to address this problem in the future.Acknowledgements
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